Clinical Trial: Evaluation of the Atlas Genetics io® CTNG System

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: IO-CTNG: A Multi-Centre Evaluation of the Atlas Genetics io® CTNG System Used in Centralised and Point of Care Settings

Brief Summary: The objective of the study is to compare Atlas Genetics io® system results with those obtained from comparator devices.

Detailed Summary:
Sponsor: Atlas Genetics Limited

Current Primary Outcome: Diagnostic Accuracy compared to positive Composite Infected Status from comparator devices [ Time Frame: Up to 7 days ]

The assessment of the diagnostic accuracy of the study device as compared to positive Composite Infected Status from comparator devices


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Atlas Genetics Limited

Dates:
Date Received: February 27, 2017
Date Started: May 18, 2017
Date Completion: January 2018
Last Updated: May 18, 2017
Last Verified: May 2017